東京医科大学病院

What 東京医科大学病院 does

東京医科大学病院 (Tokyo Medical University Hospital) is a major private university hospital located in Nishi-Shinjuku, Tokyo, operated by Tokyo Medical University (東京医科大学), a private educational corporation. Designated by Japan's Ministry of Health, Labour and Welfare as a Specific Function Hospital (特定機能病院), a Regional Cancer Care Coordination Core Hospital (地域がん診療連携拠点病院), and a Tokyo Metropolitan Disaster Core Hospital (東京都災害拠点中核病院), the hospital operates over 50 clinical departments and serves as the primary teaching facility for Tokyo Medical University's medical school. It primarily receives patients referred from regional clinics and hospitals via Japan's formal kakaritsuke medical coordination network, with a 7,700 yen designated referral fee for self-referred patients; international patients are served through guarantor organizations.

The hospital's core technology platform centers on advanced minimally invasive treatment — including a 4-unit robotic surgery system comprising the latest da Vinci 5 and da Vinci SP platforms — alongside laparoscopic, endoscopic, thoracoscopic, and catheter-based interventions. A dedicated Cell and Regenerative Medicine Center, established September 2014, conducts autologous cell therapies including bone marrow-derived mesenchymal cell transplantation for peripheral arterial disease (priced at approximately ¥2,008,463 per treatment) and S-DSC hair regeneration medicine developed jointly with Toho University and Kyorin University. The hospital also holds approval for multiple Japan Advanced Medical Care (先進医療) treatments including irreversible electroporation (NanoKnife) for liver cancer and CAR-T cell therapy (Breyanzi), and operates specialized centers for cardiovascular surgery, gastroenterology, regenerative medicine, allergy, dementia, and Kampo medicine.

Revenue is generated primarily through Japan's national health insurance reimbursement system supplemented by self-pay advanced medical treatments (ranging from ¥21,131 for rapid ophthalmic diagnostics to over ¥2 million for regenerative procedures), self-pay health screening services (人間ドック), medical documentation fees, and international patient services. The hospital pursues a referral-led and event-driven GTM model — coordinating with regional medical institutions through the 新都心医療連携懇話会 (Shintoshin Medical Coordination Council) and direct call lines, while conducting community outreach through a regular public lecture series (市民公開講座, currently at session 189). In June 2024, the institution adopted a formal University Hospital Reform Plan covering operations, education, research, care delivery, and financial management through 2029.

Name

東京医科大学病院

Legal name

東京医科大学病院

Website

https://hospinfo.tokyo-med.ac.jp

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Tokyo Medical University Hospital is a designated Specific Function Hospital in Nishi-Shinjuku, Tokyo, operating 50+ clinical departments and providing advanced tertiary care, robotic and regenerative medicine, and cancer treatment primarily to referred patients from across the Kanto region and selected international patients.

Ownership category

akta.pro rank

Product category

University Hospital Services

NAICS

General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Home Health Remote Patient Monitoring & Virtual Nursing Providers (HLAFAEAN)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Advanced medical care
• University hospital services
• Robotic surgery
• Regenerative medicine
• Cancer treatment coordination

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. National Health Insurance Medical Services: Standard medical services covered under Japan's national health insurance system, providing the majority of revenue through regulated insurance-based reimbursement for consultations, treatments, surgeries, and hospitalizations.
2. Advanced Medical Care (先進医療): Self-funded advanced medical treatments not covered by insurance, including various cutting-edge procedures such as advanced reproductive technologies, regenerative medicine, and innovative surgical techniques. Costs range from 21,131 yen to 2,008,463 yen depending on the procedure.
3. Health Screening Services (人間ドック): Comprehensive health examination services provided as自费 (self-pay) examinations for preventive healthcare and early disease detection.
4. Medical Documentation Fees: Fees for medical certificates, various certifications, and document processing services.
5. International Patient Services: Self-pay medical services for foreign patients not covered by Japanese public health insurance, coordinated through guarantor organizations and international medical coordination companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Tokyo Medical University Hospital is a Japanese university hospital delivering advanced and specialized medical care across more than 50 clinical departments, including robotic-assisted surgery (da Vinci 5 and da Vinci SP), minimally invasive surgery, cancer treatment, regenerative medicine through its Cell and Regenerative Medicine Center, reproductive medicine, cardiovascular surgery, and health screening examinations. Patient care is delivered primarily through a referral-based system from regional medical institutions, with additional self-pay advanced medical treatments and international patient services for foreign patients.

Product overview

東京医科大学病院 is a Japanese university hospital offering comprehensive medical services across multiple specialties. The hospital provides robotic-assisted surgery using da Vinci systems (da Vinci 5 and da Vinci SP), laparoscopic, endoscopic, thoracoscopic, and catheter-based minimally invasive procedures. The facility also offers advanced treatments including hair regeneration therapy (S-DSC®), CAR-T cell therapy, and various approved advanced medical treatments. The hospital operates specialized departments for cell and regenerative medicine, cancer treatment, cardiovascular surgery, and operates a dedicated minimally invasive treatment information platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Robot-Assisted Surgery (da Vinci) Minimally invasive robotic-assisted surgical procedures using the da Vinci 5 and da Vinci SP platforms across multiple specialties including urological, gynecological, cardiac, and general surgeries, performed by a 4-unit robotic surgery system with focus on next-generation surgeon training.
• Laparoscopic Surgery (腹腔鏡手術) Minimally invasive laparoscopic surgical procedures for various abdominal and general surgical conditions.

Quantifiable outcome

• Successful implementation of advanced medical technologies with proven clinical outcomes in regenerative medicine, robotic surgery, and cancer treatment

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature6 records

Partnerships

Nine partnerships are on record, tiered core, major and minor.

• 東京医科大学 (Tokyo Medical University)coreStrategic or Co-development PartnerParent university institution providing academic oversight, research collaboration, and medical education integration. The hospital serves as the primary teaching hospital for Tokyo Medical University's medical education program.
• 東京医科大学八王子医療センター (Tokyo Medical University Hachioji Medical Center)coreStrategic or Co-development PartnerAffiliated hospital within the Tokyo Medical University healthcare network, providing additional medical services and sharing resources and expertise.
• 東京医科大学茨木医療センター (Tokyo Medical University Ibaraki Medical Center)coreStrategic or Co-development PartnerAffiliated hospital within the Tokyo Medical University healthcare network, extending medical services to the Ibaraki region.
• 国際医療身元保証機関 (International Medical Guarantor Organizations)coreChannel Partner/ Reseller/ DistributorContracted international medical care coordination companies that provide guarantor services for foreign patients, including medical interpretation, appointment coordination, and cultural liaison services.
• メディフォン社 (Medifone)majorTechnology or IntegrationMedical interpretation service provider enabling communication with international patients in multiple languages through professional medical interpreters.
• Regional Medical Institutions (地域連携医療機関)coreChannel Partner/ Reseller/ DistributorNetwork of regional clinics and hospitals for patient referrals, medical coordination, and collaborative care. Includes regular conferences (新都心医療連携懇話会) and direct communication lines for seamless patient transfer.
• 東邦大学医療センター大橋病院 (Toho University Medical Center Ohashi Hospital)majorStrategic or Co-development PartnerCollaborative research partner in the development of S-DSC hair regeneration medicine, along with 杏林大学医学部付属病院.
• 杏林大学医学部付属病院 (Kyorin University Hospital)majorStrategic or Co-development PartnerCollaborative research partner in the development of S-DSC hair regeneration medicine, along with Toho University.
• 厚生労働省検疫所 (Ministry of Health Labour and Welfare Quarantine Station)minorStrategic or Co-development PartnerCollaboration on infectious disease control and guidance for international travelers.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Kyorin University Hospital: Tokyo-area private university hospital with designated clinical training status. Direct peer on the private university hospital model and existing joint research partner with TMUH on S-DSC hair regeneration development.
• Nippon Medical School Hospital: Tokyo private university hospital with designated Advanced Specific Function Hospital status, comparable advanced treatment offerings and teaching mission. Direct peer on private-university hospital model in the Tokyo market.
• Toho University Medical Center Omori Hospital: Tokyo private university hospital comparable on academic structure and clinical training designation. Existing joint research partner with TMUH on S-DSC hair regeneration, confirming direct peer alignment on research and teaching mission.
• Juntendo University Hospital: Major private Tokyo university hospital with designated Advanced Specific Function Hospital status, comparable service breadth, and similar patient demographic. Direct competitor for advanced referrals and international patient services in central Tokyo.
• Keio University Hospital: Keio University Hospital is another Tokyo-based designated Advanced Specific Function Hospital with comparable academic affiliation, comprehensive specialty coverage, and advanced treatment programs including robotic surgery. Most directly comparable as a private university teaching hospital of similar scale and patient mix.
• Tokyo Women's Medical University Hospital: Tokyo-based designated Specific Function Hospital operated by a private medical university. Comparable academic structure, advanced treatment programs, and international patient services. Differentiates with women's health and cardiology specialty areas but is a direct peer on overall scope.
• The University of Tokyo Hospital: Japan's premier national university hospital and designated Advanced Specific Function Hospital, offering comprehensive advanced care across all major specialties. Directly comparable scope, scale, and patient base as a top-tier Tokyo university hospital with significant research activity.

Broad incumbents

• St. Luke's International Hospital: Major established Tokyo general hospital with a long-standing international patient program and strong reputation in advanced care. Overlaps significantly on international and advanced services but operates as a general (non-university) acute care hospital.
• National Cancer Center Japan: Japan's premier government-designated cancer specialty center. Significant overlap on oncology given TMUH's Regional Cancer Care Coordination Core Hospital status, but operates as a focused cancer institution rather than comprehensive provider.

Regional players

• Saitama Medical University International Medical Center: Designated Advanced Specific Function Hospital with comparable robotic surgery and advanced treatment capabilities. Comparable scope but located in Saitama Prefecture rather than Tokyo, serving as a regional peer rather than direct Tokyo competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E6%9D%B1%E4%BA%AC%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E7%97%85%E9%99%A2

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 東京医科大学病院